Formulation Expertise
CoreRx™ scientists have extensive expertise in drug formulation development. We have skill providing innovative solutions to any issues that may arrive in the process, and speed getting your drug to market.
Excellence in formulation includes developing a number of prototypes. Once developed, these prototypes are subjected to rigorous testing that ultimately yields a single superior solution.
With CoreRx, the formulation we develop for your compound is never just ‘good enough.’ It is instead the best product solution distilled out of numerous painstaking and meticulous scientific formulation steps.
Formulation Development Capabilities
Formulations and optimizations are aided by the extensive use of statistical design of experiments.
- Solubilizing Water-Insoluble Compounds
- Fixed Dosage Combination Products
- Bioavailability Enhancement
- Excipient Selection
- Product Stability Enhancement
- Particle Size Reduction
- Modified & Controlled Release
- Development
- Innovative Delivery System Development
- Clinical Manufacturing Process Development
- Feasibility Studies for Dosage Form Selection
- Compatibility Studies of AI, Excipients, Delivery, & Packaging
- Dosage Form Design
- Formulation Optimization
- Taste Masking/Flavoring
- Formulation Characterization
- Process Scale-Up
- Technology Transfer
- GLP Tox Batch Manufacture
- Container/Closure Selection
- Short-Term & Accelerated Stability Studies
The scientists at CoreRx have years of experience and the necessary equipment to assist in the development of a wide range of dosage forms:
- Solubilizing water-insoluble drugs
- Stabilizing unstable molecules through formulation and excipient selection
- Taste Masking
- Bioavailability enhancement
- Excipient Selection and Compatibility
- Particle Size Reduction
- Formulation Screening (Microformulation)
- Novel Delivery System Development
- Manufacturing Process Development
CoreRx, through effective communication, will keep you informed regarding formulation approaches, timelines, and potential IP opportunities.